N. Tabet

Clinical Manifestations.
20250 citationsauthor #4
Drug Development.
20250 citationsauthor #5
Rethinking verbal fluency ‐ development of an automated toolkit for analysing traditional and executive task variants
20250 citationsauthor #3
Enhancing Early Detection of Neurodegenerative Disease Through Advanced Verbal Fluency Analysis
20250 citationsauthor #4
Clinical Manifestations.
20250 citationsauthor #3
Factors associated with dementia-related stigma in British adolescents
20241 citationsauthor #3
Do the effects of Hormone Replacement Therapy during menopause differ by APOE genotype?
20240 citationsauthor #10
Contextualizing Adolescent’s Experiences of Dementia in England
20241 citationsauthor #3
The Use of the Integrated Cognitive Assessment (ICA) to Improve the Efficiency of Primary Care Referrals to Memory Services in the Accelerating Dementia Pathway Technologies (ADePT) Study
20231 citationsauthor #4
Downregulating functional hyperactivity in APOE ε4 carriers: an important avenue for early‐life risk reduction
20230 citationsauthor #7
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.
20236 citationsauthor #24
The use of the integrated cognitive assessment to improve the efficiency of primary care referrals to memory services in the accelerating dementia pathway technologies study
20236 citationsauthor #4
Measures Determining Dementia-Related Attitudes in Adolescents: A Scoping Review
20235 citationsauthor #3
Using the Integrated Cognitive Assessment (ICA) to improve the efficiency of primary care referrals to memory services
20231 citationsauthor #5
Evidence of emerging BBB changes in mid‐age apolipoprotein E epsilon‐4 carriers
202212 citationsauthor #3
Night‐to‐night variation in sleep associates with day‐to‐day variation in vigilance, cognition, memory, and behavioral problems in Alzheimer's disease
202215 citationsauthor #5
Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial
20224 citationsauthor #21
What factors have influenced quality of life in people with dementia and their family carers during the COVID-19 pandemic: a qualitative study
202216 citationsauthor #9
Care home staff perceptions of implementing a quality of life instrument into routine care practice: A qualitative study.
20222 citationsauthor #4
Covid-19 and the quality of life of people with dementia and their carers—The TFD-C19 study
202216 citationsauthor #9
The Effect of Apolipoprotein e4 on Object Mnemonic Discrimination in Healthy Adulthood.
20220 citationsauthor #4
Bilingualism: A Global Public Health Strategy for Healthy Cognitive Aging
202115 citationsauthor #3
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
202159 citationsauthor #23
The Use of a Computerized Cognitive Assessment to Improve the Efficiency of Primary Care Referrals to Memory Services: Protocol for the Accelerating Dementia Pathway Technologies (ADePT) Study
20218 citationsauthor #4
The use of a computerised cognitive assessment to improve the efficiency of primary care referrals to memory services: Protocol for the ADePT study (Preprint)
20210 citationsauthor #4
Mid age APOE ε4 carriers show memory-related functional differences and disrupted structure-function relationships in hippocampal regions
202022 citationsauthor #4
Co-creating connected and intelligent care homes for people with dementia
20200 citationsauthor #3
Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer’s disease: the MADE Phase II, three-arm RCT
202013 citationsauthor #10
Edinburgh Research Explorer Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease
20200 citationsauthor #8
Social networks and loneliness in people with dementia of the Alzheimer-type
20190 citationsauthor #4
Cambridge Cognitive Examination and Hachinski Ischemic Score as predictors of MRI confirmed pathology in dementia: A cross‐sectional study
20192 citationsauthor #4
Psychometric properties and feasibility of use of dementia specific quality of life instruments for use in care settings: a systematic review
201923 citationsauthor #4
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life: a Cochrane Review
20194 citationsauthor #11
Using event related fMRI to examine sustained attention processes and e ects of APOE 4 in young adults
20190 citationsauthor #4
Are symptoms of insomnia in primary care associated with subsequent onset of dementia? A matched retrospective case-control study
201910 citationsauthor #2
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease
2019149 citationsauthor #8
Prospective Memory: Age related change is influenced by APOE genotype
20197 citationsauthor #3
Adaptation of the DEMQOL-Proxy for routine use in care homes: a cross-sectional study of the reliability and validity of DEMQOL-CH
201912 citationsauthor #4
Social networks and loneliness in people with Alzheimer's dementia
201980 citationsauthor #4
Using event-related fMRI to examine sustained attention processes and effects of APOE ε4 in young adults
20186 citationsauthor #4
The Elusive Nature of APOE ε4 in Mid-adulthood: Understanding the Cognitive Profile
201734 citationsauthor #2
Changes of renin‐angiotensin system‐related aminopeptidases in early stage Alzheimer's disease
201714 citationsauthor #7
Vitamin E for Alzheimer's dementia and mild cognitive impairment.
201731 citationsauthor #4
Knowledge and attitudes towards dementia in adolescent students
201748 citationsauthor #4
Is Sleep Disruption a Risk Factor for Alzheimer’s Disease?
201747 citationsauthor #3
[P1–490]: PROSPECTIVE MEMORY: AGE‐RELATED CHANGES ARE INFLUENCED BY APOE GENOTYPE
20170 citationsauthor #2
Vitamin E for Alzheimer’s dementia and mild cognitive impairment (Review)
2017134 citationsauthor #5
Herpes simplex encephalitis and Alzheimer's disease: Is there a link?
201713 citationsauthor #2
Vitamin E for Alzheimer's dementia and mild cognitive impairment.
201728 citationsauthor #4
Microbes and Alzheimer's Disease
201711 citationsauthor #31
Efficacy of Antidepressants for Depression in Alzheimer’s Disease: Systematic Review and Meta-Analysis
2017159 citationsauthor #2
Disrupted neural activity patterns to novelty and effort in young adult APOE‐e4 carriers performing a subsequent memory task
201720 citationsauthor #3
Protocol: Are primary care consultations for insomnia associated with dementia in later life?
20170 citationsauthor #6
Homocysteine concentrations in the cognitive progression of Alzheimer's disease
201744 citationsauthor #5
Putting attention in the spotlight: The influence of APOE genotype on visual search in mid adulthood
201715 citationsauthor #3
Microbes and Alzheimer's Disease.
2016462 citationsauthor #31
Structural and resting‐state MRI detects regional brain differences in young and mid‐age healthy APOE‐e4 carriers compared with non‐APOE‐e4 carriers
201649 citationsauthor #5
Evolution of clinical features in possible DLB depending on FP-CIT SPECT result
201618 citationsauthor #5
Long-Term High-Effort Endurance Exercise in Older Adults: Diminishing Returns for Cognitive and Brain Aging.
201614 citationsauthor #4
The APOE paradox: do attentional control differences in mid-adulthood reflect risk of late-life cognitive decline.
201619 citationsauthor #2
The relationship between habitual physical activity status and executive function in individuals with Alzheimer’s disease: a longitudinal, cross-lagged panel analysis
201615 citationsauthor #2
P3‐228: Impact of 18F‐ Florbetapir PET‐CT on Clinical Diagnosis and Management of Patients with Possible Alzheimer’S Disease
20160 citationsauthor #3
IC‐P‐021: Impact of 18F‐ Florbetapir Pet‐CT on Clinical Diagnosis and Management of Patients With Possible Alzheimer’s Disease
20162 citationsauthor #4
Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.
2015128 citationsauthor #14
74THE ACTION FOR HEALTH WITH EXERCISE IN ALZHEIMER'S DISEASE (AHEAD) FEASIBILITY STUDY
20151 citationsauthor #3
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life.
2015123 citationsauthor #11
Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with Lewy bodies: randomised study.
201569 citationsauthor #5
Authors' reply
20150 citationsauthor #2
Slowing the progression of Alzheimer's disease; what works?
2015104 citationsauthor #2
Aerobic exercise to improve cognitive function in older people without known cognitive impairment.
2015468 citationsauthor #4
Impaired renal function and biomarkers of vascular disease in Alzheimer's disease.
201413 citationsauthor #5
Habitual physical activity (HPA) as a factor in sustained executive function in Alzheimer-type dementia: a cohort study.
201420 citationsauthor #2
Cognitive and neural signatures of the APOE E4 allele in mid-aged adults
201483 citationsauthor #3
Hypertension and Inflammation in Alzheimer's Disease: Close Partners in Disease Development and Progression!
201455 citationsauthor #3
Pro-inflammatory cytokines IL-1β and TNF-α are not associated with plasma homocysteine concentration in Alzheimer's disease.
201311 citationsauthor #7
Prospective memory in Alzheimer-type dementia: Exploring prospective memory performance in an age-stratified sample
201313 citationsauthor #3
APOE E4 Carriers Show Prospective Memory Enhancement Under Nicotine, and Evidence for Specialisation Within Medial BA10
201322 citationsauthor #4
The effect of exercise interventions on cognitive outcome in Alzheimer's disease: a systematic review
2013190 citationsauthor #3
P4–392: Are there cognitive benefits from long‐term high‐intensity exercise in older adults?
20131 citationsauthor #3
Efficacy of non-pharmacological interventions in controlling type 2 diabetes in patients of African descent: A systematic review
20132 citationsauthor #3
Nutritional status of older adults with and without dementia
20132 citationsauthor #7
Nicotine effects on attentional reorienting in mid-age adults, and interactions with apolipoprotein E status
201314 citationsauthor #3
Antihypertensives, angiotensin, glucose and Alzheimer’s disease
201313 citationsauthor #2
MRI of carriers of the apolipoprotein E e4 allele–evidence for structural differences in normal‐appearing brain tissue in e4+ relative to e4– young adults
201331 citationsauthor #5
Blood pro‐inflammatory cytokines in Alzheimer's disease in relation to the use of acetylcholinesterase inhibitors
201321 citationsauthor #5
P1–278: Different patterns of functional connectivity changes in APOE‐ε4 carriers from early to mid‐adulthood
20130 citationsauthor #4
APOE e4 polymorphism in young adults is associated with improved attention and indexed by distinct neural signatures
201399 citationsauthor #5
Pro-inflammatory cytokines IL-1β and TNF-α are not associated with blood homocysteine concentration in Alzheimer's disease.
20120 citationsauthor #7
Low 25OH vitamin D2 levels found in untreated Alzheimer's patients, compared to acetylcholinesterase-inhibitor treated and controls.
201212 citationsauthor #3
Vitamin E for Alzheimer's dementia and mild cognitive impairment.
2012263 citationsauthor #5
Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
2012290 citationsauthor #4
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia.
201230 citationsauthor #6
Antioxidant Enzymatic Activities in Alzheimer's Disease: The Relationship to Acetylcholinesterase Inhibitors
201236 citationsauthor #6
Homocysteine in Alzheimer's disease: role of dietary folate, vitamin B6 and B12
20117 citationsauthor #7
Vitamin and herbal extracts use in patients diagnosed with dementia: What do health professionals know and think?
20118 citationsauthor #1
Diabetic Peripheral Microvascular Complications: Relationship to Cognitive Function
201121 citationsauthor #3
Acetylcholinesterase inhibitors normalise circulating vitamin D2 levels in Alzheimer's disease: an observational study
20111 citationsauthor #3
Plasma Fetuin-A is Associated with the Severity of Cognitive Impairment in Mild-to-Moderate Alzheimer's Disease
201147 citationsauthor #4
Knowledge and practices of dementia patients across Sussex in relation to vitamin and herbal extract use
20100 citationsauthor #3
Indomethacin for Alzheimer's disease (Review)
20101 citationsauthor #1

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT